Bernardini, N., Skroza, N., Rossi, G., Mambrin, A., Tolino, E., Marraffa, F., Caviglia, M., Di Guardo, A., Volpe, S., Proietti, I. and Potenza, C. (2022) “Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema”, Dermatology Reports, 14(4). doi: 10.4081/dr.2022.9447.